Related Experiment Video

Updated: Jun 1, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Role of mTOR in podocyte function and diabetic nephropathy in humans and mice

Markus Gödel1, Björn Hartleben, Nadja Herbach

  • 1Renal Division, University Hospital Freiburg, Freiburg, Germany.

The Journal of Clinical Investigation
|May 25, 2011
PubMed

Insights

Tightly controlled mTOR signaling is vital for kidney podocyte function. Dysregulation, particularly overactivation, drives diabetic nephropathy progression, suggesting mTOR inhibition as a therapeutic strategy.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Chronic glomerular diseases are a significant health concern, leading to renal failure and cardiovascular issues.
  • The precise mechanisms underlying podocyte dysfunction in these diseases remain incompletely understood.
  • The mechanistic target of rapamycin (mTOR) pathway plays a critical role in cellular homeostasis.

Purpose of the Study:

  • To investigate the role of mechanistic target of rapamycin (mTOR) signaling in maintaining glomerular podocyte function.
  • To determine the impact of mTOR dysregulation on the development and progression of glomerular diseases, including diabetic nephropathy.
  • To explore the therapeutic potential of modulating mTOR activity in podocyte protection.

Main Methods:

  • Genetic manipulation of mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) in mouse podocytes.
  • Induction of proteinuria and glomerulosclerosis in genetically modified mice.
  • Analysis of glomerular hypertrophy and hyperfiltration in human diabetic nephropathy.
  • Assessment of therapeutic effects of mTORC1 signaling inhibition in mouse models.

Main Results:

  • Genetic deletion of mTORC1 in podocytes induced proteinuria and glomerulosclerosis.
  • Simultaneous deletion of mTORC1 and mTORC2 exacerbated glomerular damage, highlighting the importance of both complexes.
  • Increased mTOR activity correlated with human diabetic nephropathy features like hypertrophy and hyperfiltration.
  • Reducing mTORC1 signaling in mice prevented glomerulosclerosis and ameliorated diabetic nephropathy progression.

Conclusions:

  • Tightly balanced mTOR activity is essential for podocyte homeostasis.
  • Dysregulated mTOR signaling, particularly overactivation, contributes to glomerular disease pathogenesis.
  • mTOR inhibition represents a promising therapeutic strategy for protecting podocytes and preventing diabetic nephropathy progression.

More Related Videos

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...